PDF电子书：LIPOPROTEINS – ROLE IN HEALTH AND DISEASES （2012） - 经典PDF电子书下载区干细胞之家



免疫细胞治疗专区	欢迎关注干细胞微信公众号

12 3 4 5 6 7 8 9 10 ... 31 下一页

返回列表

查看: 848318\|回复: 307	go [生物学相关学科类] PDF电子书：LIPOPROTEINS – ROLE IN HEALTH AND DISEASES （2012） [复制链接]

xyklmu

高级会员

Rank: 4

积分: 1184
威望: 1184
包包: 1887

优秀会员

楼主

发表于 2013-1-3 20:30 |只看该作者 |倒序浏览 |打印

本帖最后由细胞海洋于 2013-1-4 10:33 编辑 / u" G9 d6 I/ @" O7 M7 |& ?  ?

[hide][/hide]
LIPOPROTEINS – ROLE IN HEALTH AND DISEASES8 ^. d) p/ G5 K
Edited by Saša Frank and Gerhard Kostner) t1 c' `$ ]7 i2 f7 x; G- w) g! g* [. K; G

共28章 774页& C/ X/ {9 e" X  U

Contents: A8 v$ z! m& [' Z$ D
Preface XI
Section 1 Lipoprotein Structure and Assembly 1" j& H/ E! C$ l' K& H
Chapter 1 Lipoprotein Structure and Dynamics: Low Density Lipoprotein Viewed as a Highly Dynamic and Flexible Nanoparticle 30 L# ~% W  r8 }, b8 E& }
Ruth Prassl and Peter Laggner
Chapter 2 New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins
from in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease 21; g" q4 I' }- `7 Q5 W: E# t( |+ X
Benjamin Dieplinger and Hans Dieplinger
Section 2 Diagnosis of Lipoprotein Disorders 457 O' [; N* a- Y; J
Chapter 3 The Importance of Lipid and Lipoprote in Ratios in Interpretetions of Hyperlipidaemia of Pregnancy 47
D.S. Mshelia and A.A. Kullima! X( `, _5 N# t8 s  K. t$ x
Chapter 4 A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia 73
Stanislav Oravec, Johannes Mikl,
Kristina Gruber and Elisabeth Dostal3 t$ C; J9 o) A; a6 T# Q
Chapter 5 The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk 95
Göran Walldius
Chapter 6 Approaches to Access Biological Data Sources 149
Assia Rharbi, Khadija Amine, Zohra Bakkoury,
Afaf Mikou, Anass Kettani andAbdelkader Betari3 |7 Y/ _  u- O) C; {
VI Contents
Section 3 Hyper- and Dyslipoproteinemias 171
Chapter 7 Lipoproteins Impact Increasing Cardiovascular Mortality 173
Jelena Umbrasiene, Ruta-Marija Babarskiene and Jone Vencloviene
Chapter 8 Lipoproteins and Cardiovascular Diseases 197
Adebowale Saba and Olayinka Oridupa8 O* u( [, H4 Z2 q0 V6 n; L8 d2 s6 p
Chapter 9 Linking the Pathobiology of Hypercholesterolemia with the Neutrophil Mechanotransduction 223
Xiaoyan Zhang and Hainsworth Y. Shin
Section 4 Management of Hyper and Dyslipoproteinemias 253# ^" I) I9 V$ X; B. c
Chapter 10 The Confounding Factor of Apolipoprotein E on Response to Chemotherapy and Hormone Regulation Altering Long-Term Cognition Outcomes 255
Summer F. Acevedo, a/ _( l  \" ]7 t7 x3 A
Chapter 11 Anticholesterolemic and Antiatherogenic Effects of Taurine Supplementation is Model Dependent 269
Karl-Erik Eilertsen, Rune Larsen, Hanne K. Mæhre, Ida-Johanne Jensen and Edel O. Elvevoll3 d; L1 }' \$ ]. s
Chapter 12 Endoscopic Treatment of Metabolic Syndrome 289( {4 i2 S) c4 A/ e& w
Eduardo Guimarães Hourneaux de Moura, Ivan Roberto Bonotto1 ?; e! p. J' j
Orso, Bruno da Costa Martins and Guilherme Sauniti Lopes! f) C7 ~, m5 u6 X8 f0 r+ E4 z
Chapter 13 Nutritional Management of Disturbances in Lipoprotein Concentrations 303/ W9 A9 j0 N+ k! Z
Somayeh Hosseinpour-Niazi, Parvin Mirmiran and Fereidoun Azizi
Chapter 14 Cyclosporin A-Induced Hyperlipidemia 337' |( Y/ s5 T1 X" G$ F
Maaike Kockx and Leonard Kritharides
Chapter 15 Lipoproteins and Apolipoproteins of the Ageing Eye 355$ Q" }& J4 Y4 |- Q4 i. ^) \7 q
Edward Loane6 }6 V- r5 Z5 \$ k9 j* P. \) F
Section 5 Lipid Oxidation and Anti-Oxidants 3818 Y* {9 p; q( N& f: M7 l; P
Chapter 16 Pathophysiology of Lipoprotein Oxidation 383
Vikram Jairam, Koji Uchida and Vasanthy Narayanaswami
Chapter 17 Oxidized Phospholipids: Introduction and Biological Significance 409* c" B. v0 S/ h8 c% X) |
Mohammad Z. Ashraf and Swati Srivastava3 K5 ?3 U4 [1 a4 N- I' {
Contents VII
Chapter 18 HDL-Associated Paraoxonase 1 Gene Polymorphisms as a Genetic Markers for Wide Spread Diseases 4315 N& Y# ?# A7 W4 u$ w
Ivana Pejin-Grubiša3 C, K  w+ a5 p9 t, B$ @) |' J
Chapter 19 Antioxidant Complexes and Lipoprotein Metabolism – Experience of Grape Extracts Application Under Metabolic Syndrome and Neurogenic Stress 445
Andriy L. Zagayko, Anna B. Kravchenko,
Mykhaylo V. Voloshchenko and Oxana A. Krasilnikova
Chapter 20 The Anti-Atherogenic Effects of Lycopene 489
Amany M. M. Basuny
Section 6 Animal Models for Lipoprotein Research 507
Chapter 21 Animal Models as Tools for Translational Research: Focus on Atherosclerosis, Metabolic Syndrome and Type-II Diabetes Mellitus 5092 r# X7 d& M3 x% ?4 M  M3 L& p& K
Isaac Karimi
Chapter 22 Genetically Modified Animal Models for Lipoprotein Research 5336 S3 M1 D1 }. `, e- H; O- k6 E
Masashi Shiomi, Tomonari Koike and Tatsuro Ishida
Section 7 Role of Lipoproteins in Neurodegenerative Diseases 5618 S  p  l5 x8 r" s; Q3 L8 n
Chapter 23 Plasma Lipoproteins in Brain Inflammatory and Neurodegenerative Diseases 563: f2 W/ \$ O( y( Z' ^  k' I# ^
Armando Sena, Carlos Capela, Camila Nóbrega,
Véronique Férret-Sena, Elisa Campos and Rui Pedrosa
Chapter 24 Genetics of Ischemic Stroke: Emphasis on Candidate-Gene Association Studies 583
Sanja Stankovic, Milika Asanin and Nada Majkic-Singh
Chapter 25 Lipoproteins and Apolipoproteins in Alzheimer's Disease 6135 H0 H  y. J3 Z' Z
Etsuro Matsubara
Section 8 Lipoproteins and Cancer 621: q9 `) U4 p6 l9 u+ l( t' `9 A+ O5 s
Chapter 26 Lipoproteins and Cancer 623# g! S' b/ Y, r* P; S& s3 T
Caryl J. Antalis and Kimberly K. Buhman0 k: L- e# u0 g+ |+ \7 U
Chapter 27 Role of Lipoproteins in Carcinogenesis and in Chemoprevention 647- o( L; X! C  l! x1 x( ]; N
Adebowale Bernard Saba and Temitayo Ajibade

附件: 你需要登录才可以下载或查看附件。没有帐号？注册